Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
5.9% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
30
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
12
users have commented on this narrative
26
users have followed this narrative
12 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.5% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
7
users have commented on this narrative
25
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
44.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Canaan
AN
AnalystLowTarget
Consensus Narrative from 6 Analysts
Bitcoin Volatility And Regulations Will Cut ASIC Demand Yet Stabilize
Key Takeaways High regulatory uncertainty, volatile crypto markets, and dependence on mining hardware expose Canaan to unpredictable revenue, margin pressure, and competitive threats. Limited diversification and industry vulnerability to technology shifts away from energy-intensive mining may constrain long-term earnings stability and stock performance.
View narrative
US$1.50
FV
49.8% undervalued
intrinsic discount
39.32%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Cerence
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
Apple, Google And Amazon Integration Will Undermine Future Prospects
Key Takeaways Increased competition from tech giants and in-house automaker solutions threatens Cerence's partnerships, market share, and ability to differentiate its offerings. Regulatory, privacy, and customer concentration risks, combined with industry standardization, may raise costs, compress margins, and create unpredictable revenue streams.
View narrative
US$10.00
FV
10.4% overvalued
intrinsic discount
2.89%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Gevo
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
Dwindling Incentives And Sluggish Renewables Will Erode Prospects
Key Takeaways Loss of government incentives, policy uncertainty, and execution risks threaten profitability and growth, while volatile carbon markets could undermine management's revenue projections. Rising competition and delays in project deployment may erode margins, market share, and Gevo's long-term earnings sustainability.
View narrative
US$1.15
FV
50.4% overvalued
intrinsic discount
33.12%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
VNET
VNET Group
AN
AnalystLowTarget
Consensus Narrative from 13 Analysts
Chinese Data Center Buildout Will Suffer Under Mounting Pressures
Key Takeaways Overexpansion risks underused assets and squeezed margins amid maturing digital demand, increasing competition, and regulatory pressures in China's data center market. High debt levels and heavy capital needs heighten refinancing and dilution risks, while tightening tech and compliance restrictions threaten innovation and long-term profitability.
View narrative
US$5.71
FV
45.1% overvalued
intrinsic discount
14.69%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Clover Health Investments
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
Rising Costs And Regulation Will Erode Medicare Advantage Profitability
Key Takeaways Persistent cost pressures, regulatory risks, and rising competition threaten both profitability and scalability, undermining Clover Health's growth strategies. Heavy reliance on membership expansion and external funding increases vulnerability to market downturns and shareholder dilution.
View narrative
US$2.50
FV
9.2% overvalued
intrinsic discount
20.42%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Organogenesis Holdings
AN
AnalystLowTarget
Consensus Narrative from 2 Analysts
Aggressive Discounting Will Squeeze Margins While Aging Population Buoys Prospects
Key Takeaways Heightened pricing competition, regulatory uncertainty, and reliance on a narrow product portfolio create near-term margin pressures and cash flow risks. Hospital consolidation and rapid innovation threaten revenue stability, market share, and the pace of sustainable earnings growth.
View narrative
US$7.00
FV
30.1% undervalued
intrinsic discount
13.71%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Stanley Black & Decker
AN
AnalystLowTarget
Consensus Narrative from 15 Analysts
Aging Populations And Tariff Pressures Will Erode Profit Margins
Key Takeaways Demographic shifts, evolving consumer preferences, and increased competition threaten core revenue streams and require costly adaptation, reducing market share and earnings stability. Structural cost pressures from global supply chain issues, legacy obligations, and commoditization undermine pricing power, flexibility, and long-term profitability.
View narrative
US$64.00
FV
21.1% overvalued
intrinsic discount
1.79%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Travere Therapeutics
AN
AnalystLowTarget
Consensus Narrative from 14 Analysts
Regulatory Pressures And Competition Will Hamper Uptake But Hope Endures
Key Takeaways Heavy reliance on FILSPARI and persistent net losses create vulnerability to competition, regulatory changes, and setbacks in new product development. Increasing R&D expenses and pricing pressures from government controls threaten margins, limiting sustainable growth and financial flexibility despite favorable market trends.
View narrative
US$20.00
FV
10.4% undervalued
intrinsic discount
28.60%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
HelloFresh
AN
AnalystLowTarget
Consensus Narrative from 12 Analysts
Mounting Regulatory Risks And Inflation Will Erode Meal Kit Appeal
Key Takeaways Shifting consumer preferences toward sustainability and inflation-driven budget constraints are eroding demand, increasing churn, and heightening regulatory and competitive risks for HelloFresh. Operational complexity, margin pressure, and structural misalignment with tech-driven personalization and grocery industry consolidation threaten long-term profitability and market share.
View narrative
€7.60
FV
6.8% overvalued
intrinsic discount
-2.83%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Value any company in seconds
Popular companies